Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03609983 · ClinicalTrials.gov registry record · NA
Diet, Physical Activity, and Weight Trends Study
A NA study of Self-regulation, sponsored by The University of Tennessee, Knoxville.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03609983: Completed NA study of Self-regulation, sponsored by The University of Tennessee, Knoxville.
NCT03609983 is a NA study of Self-regulation that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 22 participants, below the 177-participant average among 7 other Self-regulation trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03609983, a NA study of Self-regulation, has completed, sponsored by The University of Tennessee, Knoxville.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this investigation is to is to examine if self-weighing with feedback, in which the feedback is matched to the timeframe of self-weighing, in the absence of a standard behavioral intervention assists with the self-regulation of energy balance behaviors among young adults. Participants will be randomized to one of three groups: 1) daily weighing; 2) weekly weighing; 3) no weighing for 4 weeks.
Primary Outcome
Dietary intake data for 24-hour recalls will be collected using the Automated Self-Administered 24-Hour (ASA24), Dietary Assessment Tool, version 2016, developed by the National Cancer Institute, Bethesda, MD. Participants will be registered for ASA24 at the baseline appointment. Throughout the week following the baseline appointment, participants will be randomly emailed on three days to complete three 24-hour recalls (1 weekend day, 2 weekdays) through ASA24. Participants will be randomly emai
Conditions Studied
Interventions
- OTHER Daily weighing with daily feedback on weight
- OTHER Weekly weighing with weekly feedback on weight
Study Locations (1)
Tennessee
- Healthy Eating and Activity Laboratory, University of Tennessee - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-06-12 |
| Est. Completion | 2021-08-16 |
| Phase | NA |
What the finished NCT03609983 record still lists
NCT03609983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 177-participant average among 7 other Self-regulation trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Self-regulation appearing as the primary indexed condition, and to 2 interventions - of which Daily weighing with daily feedback on weight is the first listed.
NCT03609983 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03609983 about?
NCT03609983 is a clinical study titled "Diet, Physical Activity, and Weight Trends Study". The purpose of this investigation is to is to examine if self-weighing with feedback, in which the feedback is matched to the timeframe of self-weighing, in the absence of a standard behavioral intervention assists with the self-regulation of energy balance behaviors among young adults. Participants...
What is the current status of trial NCT03609983?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2018-06-12. Estimated completion is 2021-08-16.
What conditions does trial NCT03609983 study?
This clinical trial studies the following conditions: Self-regulation.
What interventions are being tested in trial NCT03609983?
The interventions under investigation include: Daily weighing with daily feedback on weight (OTHER), Weekly weighing with weekly feedback on weight (OTHER).
Who is sponsoring clinical trial NCT03609983?
This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03609983 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self-regulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Project REST: Regulation of Eating and Sleep Topography
RECRUITING · NA
-
MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants
RECRUITING · NA
-
Investigating Baby Behavior and Family Technology Use Study
RECRUITING · NA
-
Strengthening Child Social-Emotional and Lifestyle Health in Families Experiencing Stress
ACTIVE NOT RECRUITING · NA
-
The Families and Middle School Success Project
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI